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Abstract In non-excitable cells, sustained intracellular Ca2+
increase critically depends on influx of extracellular Ca2+. Such
Ca2+ influx is thought to occur by a ‘store-operated’ mechanism,
i.e. the signal for Ca2+ entry is believed to result from the initial
release of Ca2+ from inositol 1,4,5-trisphosphate-sensitive
intracellular stores. Here we show that the depletion of cellular
Ca2+ stores by thapsigargin or bradykinin is functionally linked
to a phosphoinositide-specific phospholipase D (PLD) activity in
cultured vascular smooth muscle cells (VSMC), and that
phosphatidic acid formed via PLD enhances sustained calcium
entry in this cell type. These results suggest a regulatory role for
PLD in store-operated Ca2+ entry in VSMC. ß 2000 Feder-
ation of European Biochemical Societies. Published by Elsevier
Science B.V. All rights reserved.
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1. Introduction
In excitable cells, increases in the cytosolic free Ca2 con-
centration ([Ca2]i) occur mainly via voltage-activated Ca2
channels. In many non-excitable cells, by contrast, the stim-
ulation of phosphoinositide-speci¢c phospholipase C (PLC)
subsequent to agonist^receptor binding increases the cytosolic
inositol 1,4,5-trisphosphate (InsP3) concentration, which re-
leases Ca2 from intracellular stores [1]. This initial rise of
cellular Ca2 is followed by entry of extracellular Ca2, which
leads to a sustained Ca2 increase and allows the cellular
Ca2 stores to re¢ll [2]. The mechanism underlying the sus-
tained Ca2 in£ux is not entirely understood. Di¡erent mes-
sengers were proposed to be released upon depletion of Ca2
stores. These include a small di¡usible messenger [3], a small
monomeric GTP-binding protein [4,5], cyclic GMP [6] and
inositol phosphates [7]. Alternatively, a direct protein^protein
interaction between a regulatory protein on the stores and a
plasma membrane Ca2 channel may exist [8]. Recently, sev-
eral products of the Trp channel gene family were demon-
strated to be Ca2-store-operated channels in invertebrate
and mammalian cells [9,10]. These channels appear to be regu-
lated by lipid mediators such as polyunsaturated fatty acids
and diacylglycerols (DGs) [11,12]. Moreover, Yao and co-
worker demonstrated that SNAP-25, a protein involved in
fusion of vesicles with the plasma membrane, plays an essen-
tial role in store-operated Ca2 entry in Xenopus oocytes [13].
These authors hypothesized that the store-operated channels
themselves or membrane-bound activator molecules may exo-
cytotically be incorporated into the plasma membrane upon
store depletion.
Phospholipase D (PLD), which hydrolyzes phospholipids to
produce phosphatidic acid (PA) and the respective head
group, is a major enzyme implicated in cell proliferation
and membrane tra⁄c [14,15]. PA seems to be an important
co-factor for both protein and lipid secretion [15,16]. We
therefore examined the possible involvement of this enzyme
in store-operated calcium entry.
2. Materials and methods
2.1. Cell culture
All experiments were carried out using vascular smooth muscle cells
(VSMC) derived from rat thoracic aortas from 6-month-old male
normotensive Wistar-Kyoto rats. Cells were incubated in Dulbecco’s
modi¢ed Eagle’s medium (DMEM) containing 10% fetal calf serum
(Boehringer, Mannheim, Germany), 100 U/ml penicillin G, 100 Wg/ml
streptomycin and 2 mmol/l L-glutamine. Cultures were incubated at
37‡C in a humidi¢ed atmosphere of 95% air and 5% CO2. The me-
dium was changed initially after 24 h and then every 2^3 days. When
cells had formed a con£uent monolayer after about 8^10 days, they
were harvested by addition of 0.05% trypsin, and the culture was
continued up to eight passages. Separate experiments con¢rmed other
reports that the resting cytosolic free calcium concentration ([Ca2]i)
in cultured VSMC was not signi¢cantly di¡erent in these passages
[17]. To verify that cultured cells were VSMC, we carried out immu-
nocytochemical localization of smooth muscle-speci¢c K-actin using
FITC-labeled monoclonal antibodies ASM-1 (Progen, Heidelberg,
Germany). A viability of VSMC higher than 95% was observed by
trypan blue exclusion. Cells were made quiescent by incubation in
serum-free medium containing 0.1% bovine serum albumin, 100
U/ml penicillin and 100 Wg/ml streptomycin for 48 h.
2.2. Radiolabeling and separation of radiolabeled hydrolysis products
To monitor phospholipid-derived 1,2-DG, PA and phosphatidylbu-
tanol (PBut), cells were prelabeled with 0.5 WCi/ml [14C]arachidonic
acid (Amersham) for 24 h, or with 0.1 WCi/ml L-lyso-3-phosphatidyl-
choline (PC), [1-14C]palmitoyl (56 mCi/mmol, Amersham), for 2 h, as
previously described [16,18]. The cells were washed ¢ve times in phos-
phate-bu¡ered saline (PBS) and stimulated with 500 nmol/l thapsigar-
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gin or with 100 nmol/l bradykinin or PBS (control). Thapsigargin or
bradykinin were added at time 0. After termination of the incubation
in a liquid nitrogen bath, cells were scraped from the dishes and
radioactive lipids were extracted by the method of Folch et al. [19].
For transphosphatidylation experiments, 0.3% butanol was added
5 min before starting the incubation.
For lipid analysis, a double one-dimensional thin-layer chromatog-
raphy as previously described [16,18] was used to separate phospho-
lipids and neutral lipids of interest. After the plates had been dried
thoroughly, autoradiography was performed by using Kodak X-
OMAT ¢lm (Eastman Kodak) for 7^14 days. Radioactive bands
were cut from the silica plates and quantitated by liquid scintillation
counting using 10 ml Ultima-Gold scintillation £uid (Canberra-Pack-
ard). The identities of the labeled bands were determined based on Rf
values obtained for authentic neutral lipids and phospholipids (from
Sigma) visualized by iodine staining. [32P]Phosphatidylinositol
(PI), [32P]phosphatidylinositol-monophosphate (PIP) and [32P]phos-
phatidylinositol-bisphosphate (PIP2) turnover were examined in
VSMC prelabeled with [32P]ortho-phosphoric acid and stimulated
with thapsigargin or bradykinin. For this purpose, VSMC were incu-
bated for 3 h at 37‡C in phosphate-free DMEM^HEPES containing
0.2 mCi/ml of [32P]ortho-phosphoric acid (NEN, Du Pont). The cells
were washed ¢ve times and stimulated with 500 nmol/l thapsigargin or
100 nmol/l bradykinin. Extraction was performed with chloroform/
methanol/HCl (100:200:2, per volume). [32P]Phospholipids were de-
veloped with chloroform/acetone/methanol/acetic acid/water (40:15:
13:12:7, per volume) using silica 60 plates (Merck) impregnated
with 1% potassium oxalate, as previously described [20]. The amount
of radioactivity in PA, DG, PBut, PI, PIP and PIP2 was expressed as
percentage of total lipid.
2.3. Measurement of [Ca2+]i
Measurements of [Ca2]i were performed using the calcium-sensi-
tive dye fura 2 according to the method of Grynkiewicz et al. [21], as
described previously [22]. Monolayers of VSMC were grown on round
coverslips with a diameter of 13 mm according to the method of
Capponi et al. [23] and Okada et al. [24]. Brie£y, VSMC were washed
twice in physiological salt solution (mmol/l : NaCl, 135; KCl, 5;
CaCl2, 1; MgCl, 1; D-glucose, 5.5; HEPES, 10; pH 7.4) and then
incubated for 60 min at 37‡C with 0.5 Wmol/l fura 2-AM. The £uo-
rescence intensity of fura 2-loaded VSMC was measured at 37‡C using
a spectro£uorophotometer RF-5001 PC (Shimadzu, Tokyo, Japan)
equipped with a thermostatically controlled cuvette holder and with
intracellular calcium measurement software (Shimadzu, Du«sseldorf,
Germany). The £uorescence of fura 2 was measured using a data
sampling interval of 0.5 s with alternate excitation wavelengths of
340 and 380 nm (bandwidth, 5 nm), and emission was collected at
510 nm (bandwidth, 5 nm). After the subtraction of auto£uorescence
for each wavelength, the ratio (R) of the measured £uorescence values
at 340 and 380 nm excitation was calculated [21,22]. Digitonin
(1 mmol/l) and EGTA (5 mmol/l) were sequentially added to deter-
mine the maximum (Rmax) and minimum (Rmin) of the 340/380 nm
excitation ratio, respectively. [Ca2]i was calculated following
the equation of Grynkiewicz et al. [20]: [Ca2]i = KU(Ri3Rmin)/
(Rmax3R); K stands for KDUFmin380/Fmax380, the latter representing
the ratio of the £uorescence at 380 nm excitation measured in EGTA
plus digitonin to that measured in 1 mmol/l external Ca2 plus dig-
itonin, and KD represents the dissociation constant of fura 2 for Ca2,
which was set to be 224 nmol/l [21]. For measurements, VSMC were
preincubated with bu¡er alone for control or with 0.3% butanol for
5 min. The cells were stimulated with 500 nmol/l thapsigargin or 100
nmol/l bradykinin in the presence or absence of 1 mmol/l external
Ca2.
2.4. Cell permeabilization
VSMC (106 cells) in 10 ml of ice-cold permeabilization solution
(140 mM KCl, 10 mM glucose, 1 mM EGTA, 10 mM HEPES,
pH 7.0) were twice subjected to a 1 kV/0.4 cm discharge from a
10 WF capacitator using a Bio-Rad Gene pulser [25]. At these con-
ditions, s 85% of the cells were permeabilized as detected by uptake
of trypan blue. The permeabilization procedure was performed in the
presence of 500 WM PA (L-K-PA, L-arachidonoyl-Q-stearoyl, from Sig-
ma) dissolved in DMSO or in the presence of DMSO alone (control).
Immediately, the cells were transferred to the spectro£uorophotome-
ter, and [Ca2]i was monitored from 10 s subsequent to the perme-
abilization procedure onward. CaCl2 (20 mmol/l) was added as indi-
cated.
2.5. Statistics
Statistical analysis was performed by using the SPSS FOR WIN-
DOWS 5.01 software package (SPSS Inc.). For statistical evaluation
of the data, Friedman’s two-way ANOVA was used, and two-tailed
values of P6 0.05 were considered to be signi¢cant. The original Ca2
tracings shown in the ¢gures were superimposed by using the graphic
software GRAPHPAD-INPLOT 4.03.
3. Results
3.1. Thapsigargin- and bradykinin-induced activation of PLD in
VSMC
VSMC were prelabeled with [14C]arachidonic acid and then
Fig. 1. Thapsigargin- and bradykinin-induced activation of PLD in
VSMC. Time courses of [14C]PA (A and B), (14C]DG (C and D)
and [14C]PBut (E and F) formation were monitored in VSMC prela-
beled with [14C]arachidonic acid and stimulated with thapsigargin,
bradykinin or PBS. Cells were prelabeled with 0.5 WCi/ml
[14C]arachidonic acid (Amersham) for 24 h, and stimulated with 500
nmol/l thapsigargin (b in A,C,E) or with 100 nmol/l bradykinin (b
in B,D,F) or PBS (a in A^F). Thapsigargin (Thap) or bradykinin
(BK) were added at time 0. To examine the breakdown of phos-
phoinositides, the time courses of [32P]PI (b), [32P]PIP (E) and
[32P]PIP2 (O) turnover were monitored in VSMC prelabeled with
0.2 mCi/ml of [32P]ortho-phosphoric acid and stimulated with 500
nmol/l thapsigargin (G) or 100 nmol/l bradykinin (H). The amount
of radioactivity in PA, DG, PBut, PI, PIP and PIP2 was expressed
as percentage of total lipid. The total amount of radioactivity incor-
porated into cellular lipids ranged between 30 000 and 60 000 dpm.
In (A^F), each value represents the mean þ S.D. for three or four
determinations from a typical experiment out of three. * indicates
P6 0.01 versus time 0 according to Student’s t-test. In (G) and (H),
each point represents the mean of duplicate determinations. Similar
results were obtained in four other independent experiments.
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exposed to thapsigargin (500 nmol/l) or bradykinin (100 nmol/
l). Thapsigargin and bradykinin were chosen as agonists since
these substances release InsP3-sensitive Ca2 stores by di¡er-
ent mechanisms. Bradykinin induces Ca2 release by rapid
InsP3 formation [26], whereas thapsigargin inhibits the
Ca2-ATPase responsible for re¢lling of intracellular Ca2
stores [27]. The agonists were used at concentrations which
exert maximal e¡ects on [Ca2]i [28]. Both agents caused a
transient increase in formation of [14C]PA and [14C]DG up to
1.5^2.5-fold of basal values within 2^4 min (Fig. 1A^D).
The thapsigargin- and bradykinin-induced increase of PA
(the direct product of PLD) was the ¢rst indication for acti-
vation of PLD. However, PA and DG (the direct product of
PLC) can rapidly be interconverted by hydrolases and phos-
phatases. We therefore examined phospholipid breakdown in
the presence of n-butanol, which traps PA moieties such as
PBut. In the presence of butanol, PLD catalyzes a transphos-
phatidylation reaction, and PBut instead of PA is formed.
Butanol inhibited the thapsigargin- and bradykinin-induced
PA and DG increases in a concentration-dependent manner
(up to 80%). The inhibitory e¡ect was maximal with 0.3%
butanol, and was paralleled by the formation of [14C]PBut
(Fig. 1E,F). PBut formation unequivocally demonstrated ac-
tivation of PLD.
[14C]Arachidonic acid is mainly incorporated into phos-
phoinositides. We could not detect a signi¢cant activation of
PLD in cells labeled with [14C]lyso-PC, which is nearly com-
pletely converted to PC under the used experimental condi-
tions (data not shown). These results suggested that a phos-
phoinositide-speci¢c PLD activity plays the major role in
thapsigargin- and bradykinin-induced PLD activation. To fur-
ther strengthen this hypothesis, we examined the e¡ect of
bradykinin and thapsigargin on phosphoinositide metabolism
by [32P]ortho-phosphoric acid labeling. Addition of 500 nmol/l
thapsigargin (100 nmol/l bradykinin) caused a decrease in en-
dogenous PI to 55 þ 13 (50 þ 19)% after 4 min (n = 8), which
paralleled the increase of PA, PBut and DG described in Fig.
1A^F. Thereafter, the level of PI rose and reached a level of
77 þ 13 (80 þ 9)% of that in unstimulated cells at 5 min (n = 8).
Concomitantly, PIP2 and PIP levels did not change or in-
creased slightly at longer incubation times, indicating de
novo synthesis of phosphoinositides to replenish pools of de-
pleted inositol phospholipids (Fig. 1G,H). [32P]PA and
[32P]PBut formation showed time kinetics similar to those
observed in [14C]arachidonic acid-labeled cells.
3.2. PLD activity and capacitative calcium entry in VSMC
As there is no commercially available speci¢c PLD inhib-
itor, we used a primary alcohol to evaluate the possible in-
volvement of PA in capacitative Ca2 entry. This method has
previously been used to show the involvement of PA in secre-
tion-like processes in mast cells, ¢broblasts and CHO cells
[16,29,30]. In practice, we studied the consequences of buta-
nol-induced inhibition of PA formation on cellular Ca2 han-
dling.
In the presence and absence of extracellular Ca2, pretreat-
ment of cells with butanol did not signi¢cantly in£uence the
early [Ca2]i response (Fig. 2A^D). Thus, the release of InsP3-
sensitive Ca2 stores was apparently not in£uenced by PLD.
By contrast, the sustained thapsigargin- and bradykinin-in-
duced [Ca2]i response after 2.5 min was inhibited by butanol
Fig. 2. E¡ect of inhibition of PA formation on the thapsigargin-
and bradykinin-induced [Ca2]i increase in VSMC. [Ca2]i was mea-
sured in VSMC grown on coverslips using fura 2. VSMC were pre-
incubated with bu¡er alone for control (But 3) or with 0.3% buta-
nol (But +) for 5 min. The cells were stimulated with 500 nmol/l
thapsigargin (Thap) (A and C) or 100 nmol/l bradykinin (BK) (B
and D) in the presence (A and B) or absence (C and D) of 1 mmol/l
external calcium. At the top of (A) and (B), representative original
tracings of [Ca2]i in normal medium are depicted. The peak in-
crease in [Ca2]i (v[Ca2]i) and the sustained increase in [Ca2]i
(v[Ca2]i) after 2.5 min in the presence of extracellular Ca2 (A and
B) as well as in Ca2-free medium (C and D) are shown. Each val-
ue represents the mean ( þ S.E.M.) of n = 18^26 experiments. Black
bars: absence, open bars: presence of 0.3% butanol. * indicates
P6 0.05, ** indicates P6 0.01 compared to the appropriate control
value (no butanol pretreatment).
Fig. 3. E¡ect of depletion of InsP3-sensitive intracellular calcium
stores on the bradykinin-induced [Ca2]i response and PLD activity.
Representative tracings of [Ca2]i (A) and PA (B), in absence (F) or
presence (E) of 0.3% butanol, and summary data (C) giving the bra-
dykinin-induced Ca2 increase (v[Ca2]i) and PA (vPA) formation
in the absence (black bars) and presence (open bars) of 0.3% buta-
nol (But). 100 nmol/l bradykinin was added subsequent to depletion
of InsP3-sensitive Ca2 stores. Depletion was achieved by pretreat-
ment of VSMC with thapsigargin (500 nmol/l) in zero-Ca2/EGTA
bu¡er. Thapsigargin (Thap) and bradykinin (BK) were added at the
times indicated by the arrows. PA was determined in [14C]arachi-
donic acid-labeled cells treated as described in Fig. 1. The amount
of [14C] radioactivity in PA was expressed as percentage of total lip-
id. In (C), each value represents the mean ( þ S.E.M.) of n = 25 ex-
periments.
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in Ca2-containing medium (Fig. 2A,B). Maximal inhibition
was observed at a butanol concentration of 0.3%. In Ca2-free
medium, the late Ca2 response was not detectable either in
the presence or absence of butanol (Fig. 2C,D). These data
demonstrated that a transmembrane Ca2 £ux is the main
cause of the late Ca2 response, and that inhibition of PA
formation is associated with inhibition of Ca2 entry.
Next, we examined PA formation and capacitative Ca2
in£ux after sequential addition of thapsigargin and bradyki-
nin. As shown in Fig. 3B, the depletion of Ca2 stores by
thapsigargin resulted in enhancement and prolongation of
subsequent bradykinin-induced PA formation. Despite the de-
pletion of InsP3-sensitive Ca2 stores by thapsigargin, brady-
kinin still induced a substantial increase of [Ca2]i (Fig. 3A).
This increase was only slightly smaller than that produced by
bradykinin in untreated VSMC. Thus, the failure to release
Ca2 from InsP3-sensitive stores seems to be compensated for
by an increased Ca2 in£ux. Moreover, the bradykinin-in-
duced [Ca2]i response in thapsigargin-treated cells depended
even more on PLD than in untreated cells. The increases in
[Ca2]i and PA were inhibited by 60^80% in the presence of
butanol (Fig. 3A^C).
To monitor the store-operated Ca2 in£ux and its PLD-
dependence more directly, we performed an experiment in
which Ca2 was added after thapsigargin-induced depletion
of InsP3-sensitive Ca2 stores in Ca2-free medium. As shown
in Fig. 4A, the resulting increase of cellular Ca2 was mark-
edly inhibited in the presence of butanol, further supporting
the suspicion that the PLD-dependent increase in [Ca2]i orig-
inates mainly from the in£ux of extracellular Ca2.
We also examined the in£uence of exogenously added PA
on Ca2 entry. The addition of PA dissolved in DMSO did
not induce Ca2 entry. Vigorous sonication just before addi-
tion to the cells induced a weak response. Direct introduction
of PA into electropermeabilized cells, however, induced a sig-
ni¢cant Ca2 in£ux (Fig. 4B). Electroporation per se prior to
the addition of Ca2 resulted in a slight increase of the cellular
Ca2 concentration (‘control’ in Fig. 4B). However, the in-
crease of [Ca2]i was several fold higher, when the electro-
poration was performed in the presence of PA. The rapid
increase of [Ca2]i in electropermeabilized cells peaked 50^
60 s after the addition of CaCl2, and it decreased at longer
incubation times.
4. Discussion
We have shown that two agonists which induce the release
of InsP3-sensitive Ca2 stores by di¡erent mechanisms acti-
vate PLD subsequent to the initial Ca2 response in VSMC.
In arachidonic acid-labeled cells, addition of bradykinin or
thapsigargin stimulated a monophasic accumulation of
[14C]PA, within 2^4 min. The rise in PA preceded or paral-
leled that of DG which was inconsistent with PLC/DG kinase
pathway being the source of PA and suggested the involve-
ment of PLD. PLD activation was con¢rmed by the detection
of bradykinin-/thapsigargin-mediated phosphatidyl transfer,
producing [14C]PBut instead of [14C]PA in the presence of
butanol.
PLD-mediated accumulation of PA and PBut was observed
in arachidonic acid-labeled VSMC. Arachidonic acid is
mainly incorporated into phosphoinositides, and we could
not detect a signi¢cant activation of PLD in [14C]lyso-PC-
labeled cells. These data suggested that phosphoinositides
are a major source for thapsigargin- and bradykinin-induced
PA formation. This contention was further supported by the
observation that PI hydrolysis in [32P]ortho-phosphoric acid-
labeled VSMC paralleled the increases of PA and PBut and
DG.
It is generally assumed that the depletion of cellular Ca2
stores by thapsigargin is not accompanied by the hydrolysis of
PIP2 [31,32]. This assumption is in accordance with the here
described data. A slight increase of PIP2 and PIP rather than
hydrolysis of PIP2 was registered 2^4 min after addition of
thapsigargin or bradykinin. The thapsigargin- or bradykinin-
induced hydrolysis of PI, however, has not been studied in
detail in previous studies. Moreover, most studies focused on
very early second messenger responses (within the ¢rst 30 s
after stimulation), when PIP2 is hydrolyzed by the action of
PLC, triggering the formation of InsP3 and the initial release
of cellular Ca2 stores.
The existence of a PI-speci¢c PLD has previously been
shown in pancreas cells [33] and in neutrophils [34]. For the
¢rst time, the present study points to a possible physiological
function of a cellular PI-PLD activity. The dose- and time-
related decline in PA accumulation observed in the presence
of butanol was similar to butanol-mediated inhibition of sus-
tained Ca2 entry, suggesting that PI-derived PA could be of
importance in store-operated Ca2 entry at longer stimulation
times. Of course, it cannot entirely be excluded that butanol
in£uenced the Ca2 in£ux by unspeci¢c mechanisms (e.g. by
Fig. 4. In£uence of PLD and PA on capacitative Ca2 in£ux. (A)
In the absence of extracellular Ca2, the InsP3-sensitive Ca2 stores
of VSMC were depleted by addition of thapsigargin (500 nmol/l).
Subsequently, extracellular Ca2 was increased by adding CaCl2 (20
mmol/l). [Ca2]i was measured with fura 2 in absence or presence of
0.3% butanol, as described in Fig. 2. (B) VSMC (106 cells) in 10 ml
of ice-cold permeabilization solution were twice subjected to a 1 kV/
0.4 cm discharge from a 10 WF capacitator using a Bio-Rad Gene
pulser. The permeabilization procedure was performed in the pres-
ence of 500 WM PA (L-K-PA, L-arachidonoyl-Q-stearoyl) dissolved in
DMSO or in the presence of DMSO alone (control). Immediately,
the cells were transferred to the spectro£uorophotometer, and
[Ca2]i was monitored. The addition of CaCl2 (20 mmol/l) is indi-
cated by the arrow.
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others than inhibition of PA formation). For several reasons,
however, this possibility is less likely. First, we found a close
temporal relationship between the inhibitory e¡ect of butanol
on PA formation and [Ca2]i increase. Second, inhibition of
PA formation and Ca2 response were dependent on the bu-
tanol concentration used, showing maximal e¡ects at identical
concentrations in both cases. Third, the sequential application
of thapsigargin and bradykinin enhanced both the PLD acti-
vation and the Ca2 response. Fourth, only the sustained
Ca2 entry was inhibited by butanol; the early Ca2 response,
by contrast, was not in£uenced by this treatment. Fifth, the
direct introduction of PA into permeabilized VSMC just prior
to the extracellular addition of Ca2 greatly enhanced Ca2
entry.
The postulated involvement of PLD in sustained Ca2 entry
is in apparent contradiction with a previous study, which
failed to detect thapsigargin-induced activation of PLD in
human lymphocytes [35]. Similarly discrepant results were ob-
tained regarding the involvement of PKC, which limits the
rise of Ca2 in lymphocytes [35], but appears to stimulate
store-operated Ca2 entry in pancreatic cells and VSMC
[36,37]. Altogether, these observations give further support
for the hypothesis, originally proposed by Louzao et al.,
that either subtypes of store-operated Ca2 channels are ex-
pressed in di¡erent cells or that a single channel type may
exist which is di¡erentially regulated [38].
From the present study no ¢rm conclusion can be drawn as
to which mechanism underlies the putative role of PA in sus-
tained Ca2 entry. It is of interest that the putative ‘calcium
in£ux factor’ postulated by Randriamampita and Tsien to
mediate store-operated Ca2 in£ux is a non-protein 6 500
D phosphorylated pH-stable anion [3], and thus shares some
properties of PA. In this respect, it is noteworthy that PA
itself was proposed to act as a ionophore [39^42], and thereby
may stimulate Ca2 in£ux by direct interaction with the plas-
ma membrane. Alternatively, PA might serve as a substrate
for PA-phosphohydrolases or PA-speci¢c phospholipases. The
DGs or fatty acids released by these reactions might then
stimulate membrane channels, which mediate store-operated
Ca2 in£ux. Finally, it has recently been demonstrated that a
protein involved in membrane fusion (SNAP-25) plays an
essential role in store-operated Ca2 entry in Xenopus oocytes
[11]. The involvement of small G-proteins in store-operated
Ca2 entry has previously been suggested [4,5]. Fusion pro-
teins, small G-proteins, PA and PIP2 closely act together in
membrane tra⁄cking [15]. It was shown that small G-proteins
are important activators of PLD [43,44], and that PA (togeth-
er with PIP2) is essential for the formation of certain types of
transport vesicles [30,45]. Thus, PLD activation and PA lib-
eration upon cellular depletion of intracellular Ca2 stores
could support vesicle formation and incorporation of Ca2
channels into the plasma membrane, and thereby contribute
to the sustained Ca2 entry.
In summary, we have shown that the sustained Ca2 in£ux
in response to thapsigargin and bradykinin is associated with
activation of a PLD activity in VSMC. PA formed via PLD
may play a regulatory role in store-operated Ca2 entry in
VSMC, possibly by altering the biophysical properties of cel-
lular membranes and interfering with a signal transduction
and/or a secretion-like process.
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